Jones Day (Brussels)

Mario Todino

Jones Day (Brussels)
Lawyer (Partner)

Mario Todino is partner at Jones Day (Brussels) and before he was partner at Gianni Origoni Grippo & Partners (Brussels). He is an expert of mergers, cartels, state aids and Internal Market. Has acquired an extensive and qualified experience of more than 15 years in the field of EC and national antitrust Law, by working for the Italian Competition Authority (Legal Service and Cabinet of the President), the EC Court of Justice, the Directorates for Internal Market and for Competition of the European Commission. Since joining the firm in 2007, he has built a strong EC and antitrust practice, assisting on a regular basis some of the major Italian and International groups. After graduating in Law from the University of Naples in 1990, he obtained an LL.M. in "European Law Studies" from the College of Europe of Bruges (Belgium). He is Co-Author of "La disciplina della concorrenza in Italia (Competition Law in Italy)", edited by "Il Mulino" (2nd ed. 2010) and he published several articles and essays. He is admitted to the Italian Bar. He speaks Italian, English and French.

Linked authors

Jones Day (Sydney)
Jones Day (Mexico)
Jones Day (Brussels)
Jones Day (New York)
Jones Day (Brussels)

Articles

1473 Bulletin

Charlotte Breuvart, Eric Barbier de la Serre, Marta Delgado Echevarría, Yvan N. Desmedt, Mario Todino, Alexandre G. Verheyden, Philipp Werner The EU Commission issues its State aid guidance on national recovery and resilience plans and makes it clear that all investment projects must comply with State aid rules

412

In Short The Situation: The European Commission has launched its largest ever stimulus package to support recovery of EU economies from the COVID-19 pandemic’s unprecedented economic and social disruption. Each EU Member State must submit a recovery plan and funding requests for Commission (...)

Alberto Bacchiega, Chloé MacEwen, Mario Todino, Stéphane Dionnet The EU Commission approves subject to remedies a merger in the healthcare sector addressing the issues of potential competition and unilateral effects in innovative markets (Johnson & Johnson / Guidant)

581

"Johnson & Johnson/Guidant: potential competition and unilateral effects in innovative markets"* 1. Introduction Following an in-depth investigation, on 25 August 2005 the European Commission authorised under the Merger Regulation the planned $ 24 billion (around € 18 billion) acquisition (...)

Send a message